Baird advocates medtech companies such as Alcon, Stryker, and Cooper due to product and pricing strengths. Belief is strong in Alcon's 2024 margin possibilities, Stryker's premium pricing and predicted robust orthopedic demand, and projected revenue growth for Boston Scientific and Axonics.
Gapping up $Rivian Automotive(RIVN.US)$+6% (The company reported a first-quarter loss that was narrower than expected. Rivian also said it's still on track to meet a 50,000-vehicle production target for 2023.) $Celsius Holdings(CELH.US)$+11.1% (The company posted a strong earnings report. Celsius posted 40 cents in earnings per share for the first quarter, more than doubling the 19-cent consensus estimate of analysts polled by Str...
Exact Sciences Price Target Raised to $85.00/Share From $55.00 by Craig-Hallum $精密科學(EXAS.US)$Price Target Raised to $85.00/Share From $55.00 by Craig-Hallum. Baird Upgrades Alcon to Outperform, Raises Price Target to $90 Baird analyst Jeff Johnson upgrades$Alcon(ALC.US)$from Neutral to Outperform and raises the price target from $75 to $90. BofA Securities Upgrades Celsius Holdings to Buy, Raises Price Target to $125 B o...
Jefferies Downgraded to Market Perform From Outperform at Keefe Bruyette Keefe Bruyette analyst Michael Brown downgraded$傑富瑞(JEF.US)$to Market Perform from Outperform with a price target of $37, down from $38. Jefferies faced a tough operating environment in Q4 due to weaker than expected equity capital markets and advisory revenues as well as a higher comp ratio, Brown tells investors in a research note. Coupa Softwa...
Alcon股票討論區
2023Q1營收增長7.5%,營業利潤增長8.9%,淨利潤增長3.6%。
目前119.5倍市盈率看起來相當離譜。
專欄Today's Pre-Market Stock Movers: ABNB, RIVN, AFRM, SPCE and More
$Rivian Automotive(RIVN.US)$ +6% (The company reported a first-quarter loss that was narrower than expected. Rivian also said it's still on track to meet a 50,000-vehicle production target for 2023.)
$Celsius Holdings(CELH.US)$ +11.1% (The company posted a strong earnings report. Celsius posted 40 cents in earnings per share for the first quarter, more than doubling the 19-cent consensus estimate of analysts polled by Str...
專欄US Top Rating Updates on 5/10: PYPL, EXAS, CELH, GTLB and More
$精密科學(EXAS.US)$ Price Target Raised to $85.00/Share From $55.00 by Craig-Hallum.
Baird Upgrades Alcon to Outperform, Raises Price Target to $90
Baird analyst Jeff Johnson upgrades $Alcon(ALC.US)$ from Neutral to Outperform and raises the price target from $75 to $90.
BofA Securities Upgrades Celsius Holdings to Buy, Raises Price Target to $125
B o...
專欄US Top Gap Ups and Downs on 5/3: AMD, VOD, SBUX, EL and More
Gap Ups
1. $尤納姆集團(UNM.US)$ - up 5.1%
2. $Generac(GNRC.US)$ - up 5.0%
3. $Builders FirstSource(BLDR.US)$ - up 4.9%
4. $Livent(LTHM.US)$ - up 4.4%
5. $培生(PSO.US)$ - up 4.1%
6. $Verisk分析(VRSK.US)$ - up 3.6%
7. $安信龍保險(AIZ.US)$ - up 2.7%
8. $沃達豐(VOD.US)$ - up...
AKO Capital:
專欄US Top Gap Ups and Downs on 4/21: SAP, PG, NVO, WRB and More
Gap Ups
1. $SAP SE(SAP.US)$ - up 3.2%
2. $費森尤斯醫療(FMS.US)$ - up 3.1%
3. $HCA醫療(HCA.US)$ - up 2.2%
4. $寶潔(PG.US)$ - up 2.1%
5. $諾和諾德(NVO.US)$ - up 1.5%
6. $Alcon(ALC.US)$ - up 1.2%
7. $CyberArk(CYBR.US)$ - up 1.0%
8. $阿卡迪亞醫療保健(ACHC.US)$ - up 0.9%...
專欄US Top Gap Ups and Downs on 4/10: MU, WDC, BIDU, UMC and More
Gap Ups
1. $先鋒自然資源(PXD.US)$ - up 4.1%
2. $美光科技(MU.US)$ - up 3.1%
3. $西部數據(WDC.US)$ - up 3.0%
4. $SiteOne Landscape Supply(SITE.US)$ - up 1.1%
5. $EQT能源(EQT.US)$ - up 0.7%
6. $美國網存(NTAP.US)$ - up 0.6%
7. $中華電信(CHT.US)$ - up 0.3%...
專欄US Top Gap Ups and Downs on 3/30: PHG, JD, OSH, LOGI and More
Gap Ups
1. $飛利浦(PHG.US)$ - up 4.5%
2. $Oak Street Health(OSH.US)$ - up 4.3%
3. $京東(JD.US)$ - up 3.7%
4. $AngloGold Ashanti(AU.US)$ - up 3.2%
5. $Alcon(ALC.US)$ - up 3.0%
6. $必和必拓(BHP.US)$ - up 2.6%
7. $愛立信(ERIC.US)$ - up 2.5%
8. $Paycom Software(PAYC.US)$ - up 2.1%...
專欄US Top Rating Updates on 12/22: JEF, COUP, BSX, COO and More
Keefe Bruyette analyst Michael Brown downgraded $傑富瑞(JEF.US)$ to Market Perform from Outperform with a price target of $37, down from $38. Jefferies faced a tough operating environment in Q4 due to weaker than expected equity capital markets and advisory revenues as well as a higher comp ratio, Brown tells investors in a research note.
Coupa Softwa...
暫無評論